GenOway Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 128

Employees

  • Stock Symbol
  • ALGEN

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $3.97
  • (As of Wednesday Closing)

GenOway General Information

Description

Genoway SA specializes in genetic designs to serve genetically modified (GM) mice, rat and cell lines for the biopharmaceutical industries and research industries.

Contact Information

Website
www.genoway.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 31 Rue Saint Jean de Dieu
  • 69007 Lyon
  • France
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
PAR
Corporate Office
  • 31 Rue Saint Jean de Dieu
  • 69007 Lyon
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenOway Stock Performance

As of 15-Jan-2025, GenOway’s stock price is $3.97. Its current market cap is $36.3M with 9.2M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.97 $3.95 $3.51 - $5.34 $36.3M 9.2M 6.48K $0.17

GenOway Financials Summary

As of 30-Jun-2024, GenOway has a trailing 12-month revenue of $23.2M.

In Thousands,
USD 		TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 37,792 47,414 38,973 47,650
Revenue 23,180 21,692 17,930 16,575
EBITDA 6,439 6,833 3,664 1,863
Net Income 1,359 1,696 818 (381)
Total Assets 34,004 35,199 35,307 36,978
Total Debt 6,834 7,996 9,701 12,257
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GenOway Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GenOway‘s full profile, request access.

Request a free trial

GenOway Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Genoway SA specializes in genetic designs to serve genetically modified (GM) mice, rat and cell lines for the biopharmac
Biotechnology
Lyon, France
128 As of 2024

Hyderabad, India
 

Zug, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GenOway Competitors (24)

One of GenOway’s 24 competitors is Vivo Bio Tech, a Corporation company based in Hyderabad, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vivo Bio Tech Corporation Hyderabad, India
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland
Nimbus Therapeutics Venture Capital-Backed Boston, MA
Caribou Biosciences Formerly VC-backed Berkeley, CA
Precision BioSciences Formerly VC-backed Durham, NC
You’re viewing 5 of 24 competitors. Get the full list »

GenOway Patents

  • 36

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • Pending

  • Expiring in next 12 mo

GenOway Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1814998-A2 Animal models comprising at least one conditional ko and one conditional ki Active 08-Nov-2004
EP-1814998-B1 Animal models comprising at least one conditional ko and one conditional ki Inactive 08-Nov-2004
US-20090062477-A1 Animal models comprising at least one conditional ko and one conditional ki Inactive 08-Nov-2004
AU-2002333980-A1 Cell and transgenic animal modelling human antigenic presentation and their uses Inactive 13-Jul-2001
EP-1414949-A1 Cell and transgenic animal modelling human antigenic presentation and their uses Inactive 13-Jul-2001 C12N15/8509
To view GenOway’s complete patent history, request access »

GenOway Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenOway Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GenOway‘s full profile, request access.

Request a free trial

GenOway Acquisitions (2)

GenOway’s most recent deal was a Merger/Acquisition with Axenis. The deal was made on 06-Sep-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Axenis 06-Sep-2018 Merger/Acquisition Pharmaceuticals
Murinus 12-Jan-2005 Merger/Acquisition Other Commercial Services
To view GenOway’s complete acquisitions history, request access »

GenOway FAQs

  • When was GenOway founded?

    GenOway was founded in 1999.

  • Where is GenOway headquartered?

    GenOway is headquartered in Lyon, France.

  • What is the size of GenOway?

    GenOway has 128 total employees.

  • What industry is GenOway in?

    GenOway’s primary industry is Biotechnology.

  • Is GenOway a private or public company?

    GenOway is a Public company.

  • What is GenOway’s stock symbol?

    The ticker symbol for GenOway is ALGEN.

  • What is the current stock price of GenOway?

    As of 15-Jan-2025 the stock price of GenOway is $3.97.

  • What is the current market cap of GenOway?

    The current market capitalization of GenOway is $36.3M.

  • What is GenOway’s current revenue?

    The trailing twelve month revenue for GenOway is $23.2M.

  • Who are GenOway’s competitors?

    Vivo Bio Tech, CRISPR Therapeutics, Nimbus Therapeutics, Caribou Biosciences, and Precision BioSciences are some of the 24 competitors of GenOway.

  • What is GenOway’s annual earnings per share (EPS)?

    GenOway’s EPS for 12 months was $0.17.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »